Comments
Loading...

Collegium Pharmaceutical

COLLNASDAQ
Logo brought to you by Benzinga Data
$38.78
1.43.75%
At Close: -
$38.20
-0.58-1.49%
After Hours: 5:20 PM EDT
15 minutes delayed
Consensus Rating1
Buy
Highest Price Target1
$50.00
Lowest Price Target1
$37.00
Consensus Price Target1
$42.00

Collegium Pharmaceutical (NASDAQ:COLL) Stock, Analyst Ratings, Price Targets, Forecasts

Collegium Pharmaceutical Inc has a consensus price target of $42 based on the ratings of 6 analysts. The high is $50 issued by HC Wainwright & Co. on September 5, 2024. The low is $37 issued by Piper Sandler on August 9, 2024. The 3 most-recent analyst ratings were released by HC Wainwright & Co., Piper Sandler, and Truist Securities on September 5, 2024, August 9, 2024, and August 9, 2024, respectively. With an average price target of $43 between HC Wainwright & Co., Piper Sandler, and Truist Securities, there's an implied 12.56% upside for Collegium Pharmaceutical Inc from these most-recent analyst ratings.

Analyst Trends and Forecast
0
0
0
0
Jun
0
0
0
0
Jul
1
Aug
0
0
0
0
Sep
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
3.8
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

HC Wainwright & Co.
Piper Sandler
Truist Securities
Jefferies
Truist Securities

1calculated from analyst ratings

Analyst Ratings for Collegium Pharmaceutical

Data brought to you by Benzinga APIs

FAQ

Q

What is the target price for Collegium Pharmaceutical (COLL) stock?

A

The latest price target for Collegium Pharmaceutical (NASDAQ:COLL) was reported by HC Wainwright & Co. on September 5, 2024. The analyst firm set a price target for $50.00 expecting COLL to rise to within 12 months (a possible 30.88% upside). 16 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Collegium Pharmaceutical (COLL)?

A

The latest analyst rating for Collegium Pharmaceutical (NASDAQ:COLL) was provided by HC Wainwright & Co., and Collegium Pharmaceutical maintained their buy rating.

Q

When was the last upgrade for Collegium Pharmaceutical (COLL)?

A

The last upgrade for Collegium Pharmaceutical Inc happened on July 30, 2024 when HC Wainwright & Co. raised their price target to $47. HC Wainwright & Co. previously had a neutral for Collegium Pharmaceutical Inc.

Q

When was the last downgrade for Collegium Pharmaceutical (COLL)?

A

The last downgrade for Collegium Pharmaceutical Inc happened on May 10, 2024 when Needham changed their price target from N/A to N/A for Collegium Pharmaceutical Inc.

Q

When is the next analyst rating going to be posted or updated for Collegium Pharmaceutical (COLL)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Collegium Pharmaceutical, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Collegium Pharmaceutical was filed on September 5, 2024 so you should expect the next rating to be made available sometime around September 5, 2025.

Q

Is the Analyst Rating Collegium Pharmaceutical (COLL) correct?

A

While ratings are subjective and will change, the latest Collegium Pharmaceutical (COLL) rating was a maintained with a price target of $47.00 to $50.00. The current price Collegium Pharmaceutical (COLL) is trading at is $38.20, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch